Inflammatory peripheral neuropathies — Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and vasculitic neuropathies requiring immune-modulating therapy — represent clinically complex and commercially significant neuropathy treatment market segments, with the Peripheral Neuropathy Market reflecting the established and...

The "Silver Tsunami" is reshaping the demand for neurological care in 2026. The Peripheral Neuropathy Market is expanding rapidly because the global population of people aged 65 and older is projected to reach 1.5 billion by 2050. As we age, our nervous system naturally becomes more "Fragile," making us more susceptible to "Idiopathic Neuropathy"—nerve damage that occurs without a clear...